Melissa Morgan
Endocrinology, Diabetes & Metabolism · Jacksonville, FLNPI 1821071903
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,050 of the $28,330 with a category attached, or 74.3%. AstraZeneca accounts for 83.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2020 at $9,419 and has fallen 96.3% since, to $345 in 2025.
Across 345 payments — averaging $82.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$24K
- Novo Nordisk$633
- Insulet Corporation$544
- Sanofi-aventis U.S. LLC$370
- Amgen$362
- Mannkind Corporation$324
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$21,05074%
- Travel & lodging$9703%
- Food & beverage$6,28522%
- Education$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 64 | $23,603 |
| Novo Nordisk | 53 | $633 |
| Insulet Corporation | 29 | $544 |
| Sanofi-aventis U.S. LLC | 22 | $370 |
| Amgen(2 entities) | 16 | $362 |
| Mannkind Corporation | 27 | $324 |
| Lilly USA, LLC | 15 | $279 |
| Medtronic | 14 | $274 |
| Boehringer Ingelheim | 16 | $237 |
| Aroa Biosurgery Incorporated | 1 | $200 |
| Abbott | 12 | $183 |
| Zealand Pharma US, Inc. | 8 | $178 |
| Merck | 12 | $164 |
| Valeritas, Inc. | 7 | $161 |
| Dexcom, Inc. | 8 | $118 |
| Amarin Pharma, Inc. | 5 | $100 |
| Corcept Therapeutics | 4 | $89 |
| AbbVie | 6 | $87 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| Sanofi Pasteur Inc. | 4 | $76 |
| Shire North American Group Inc | 5 | $75 |
| IBSA Pharma Inc. | 3 | $46 |
| Tandem Diabetes Care, Inc. | 3 | $43 |
| Antares Pharma, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Nalpropion Pharmaceuticals LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Vivus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,330 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Jacksonville
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Wasim DeebJacksonville$286K
- Khurram WadudJacksonville$77K
- Senan SultanJacksonville$55K
- Firas WardaJacksonville$38K
- Maria Hurtado AndradeJacksonville$36K
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.